• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans
  • .org
  • Districts
  • Media
  • SupportUs
  • Collaborate
  • Contact
  • Search
  • Join


Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.


Photo

Advanced Cell Technology: A Key Patent Critique

Started by ImmInst , Apr 08 2014 01:18 PM

  • Please log in to reply
1 reply to this topic

#1 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 08 April 2014 - 01:18 PM


Advanced Cell Technology: A Key Patent Critique
Seeking Alpha - Apr 8, 2014
This is a follow up to my prior article: BioTime Joins Advanced Cell Technology In The AMD Race. A lot has happened in the three week span since I wrote the article.

View the full article


#2 ImmInst

  • Topic Starter
  • Admin, Director robot
  • 2,350 posts
  • 72 ₮

Posted 15 April 2014 - 12:45 PM

Advanced Cell Technology: A Key Patent Critique (Part II)
Seeking Alpha - Apr 15, 2014
Neither Biotime nor anyone else engaged in the process of manufacturing RPE cells can avoid this heterogeneous culture as the monolayers are formed and mature during the process - those cultures will always "contain" Pax6- and bestrophin+ RPE cells.

View the full article
Back to Ventures & Markets


0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users

  1. LONGECITY
  2. → Round Table Discussion
  3. → Business
  4. → Ventures & Markets
  5. site rules